39,965 Shares in Teladoc Health, Inc. (NYSE:TDOC) Purchased by Vinva Investment Management Ltd

Vinva Investment Management Ltd acquired a new position in Teladoc Health, Inc. (NYSE:TDOC) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 39,965 shares of the health services provider’s stock, valued at approximately $363,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. GSA Capital Partners LLP bought a new position in Teladoc Health in the 3rd quarter worth about $92,000. Jennison Associates LLC bought a new position in Teladoc Health in the 3rd quarter worth about $1,544,000. Intech Investment Management LLC bought a new position in Teladoc Health in the 3rd quarter worth about $310,000. Massachusetts Financial Services Co. MA grew its stake in Teladoc Health by 477.1% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 370,093 shares of the health services provider’s stock worth $3,397,000 after acquiring an additional 305,961 shares in the last quarter. Finally, MetLife Investment Management LLC grew its stake in Teladoc Health by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 98,504 shares of the health services provider’s stock worth $904,000 after acquiring an additional 55,503 shares in the last quarter. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Price Performance

Shares of TDOC opened at $8.43 on Friday. The company has a market cap of $1.46 billion, a price-to-earnings ratio of -1.46 and a beta of 1.27. Teladoc Health, Inc. has a twelve month low of $6.76 and a twelve month high of $15.43. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The company has a 50 day moving average of $10.42 and a two-hundred day moving average of $9.73.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). The company had revenue of $640.49 million during the quarter, compared to analysts’ expectations of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. As a group, analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the firm’s stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the transaction, the insider now owns 64,308 shares of the company’s stock, valued at approximately $541,473.36. This trade represents a 14.62 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.95% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have commented on TDOC shares. Bank of America upped their target price on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research note on Wednesday, February 12th. Royal Bank of Canada increased their price objective on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Oppenheimer dropped their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research note on Friday, January 24th. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a research note on Thursday, February 27th. Finally, Piper Sandler dropped their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a research note on Thursday, February 27th. Eleven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $11.26.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.